JULIANNA BERGKAMP: Open Payments
NPI 1679704845 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,164 in 163 payments from 49 companies in 2025. Trend: 2023 $3,139 · 2024 $3,309 · 2025 $3,164
Food & beverage: $2,866Education: $222Consulting: $75
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $310 |
| ABBVIE INC. | 15 | $273 |
| Daiichi Sankyo Inc. | 10 | $263 |
| AstraZeneca Pharmaceuticals LP | 11 | $233 |
| PFIZER INC. | 12 | $159 |
| Celgene Corporation | 9 | $155 |
| Regeneron Healthcare Solutions, Inc. | 7 | $147 |
| SEAGEN INC. | 1 | $99 |
| Stemline Therapeutics Inc. | 6 | $96 |
| GlaxoSmithKline, LLC. | 5 | $88 |
Products named: Enhertu, EPKINLY, LIBTAYO, PLUVICTO, VENCLEXTA, BREYANZI, KEYTRUDA, Orserdu.
Industry payments across KS — which companies pay providers there.
